AAAAAA
Results:
1-7
|
Results: 7
Authors:
Vetvicka, V
Vetvickova, J
Fusek, M
Citation: V. Vetvicka et al., Role of procathepsin D activation peptide in prostate cancer growth, PROSTATE, 44(1), 2000, pp. 1-7
Authors:
Yan, J
Vetvicka, V
Xia, Y
Hanikyrova, M
Mayadas, TN
Ross, GD
Citation: J. Yan et al., Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan, IMMUNOPHARM, 46(1), 2000, pp. 39-54
Authors:
Vetvicka, V
Vetvickova, J
Fusek, M
Citation: V. Vetvicka et al., Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development, BREAST CANC, 57(3), 1999, pp. 261-269
Authors:
Ross, GD
Vetvicka, V
Yan, J
Xia, Y
Vetvickova, J
Citation: Gd. Ross et al., Therapeutic intervention with complement and beta-glucan in cancer, IMMUNOPHARM, 42(1-3), 1999, pp. 61-74
Authors:
Yan, J
Vetvicka, V
Xia, Y
Coxon, A
Carroll, MC
Mayadas, TN
Ross, GD
Citation: J. Yan et al., beta-glucan, a "Specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptortype 3 (CD11b/CD18), J IMMUNOL, 163(6), 1999, pp. 3045-3052
Authors:
Xia, Y
Vetvicka, V
Yan, J
Hanikyrova, M
Mayadas, T
Ross, GD
Citation: Y. Xia et al., The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells, J IMMUNOL, 162(4), 1999, pp. 2281-2290
Authors:
Vetvicka, V
Hanikyrova, M
Vetvickova, J
Ross, GD
Citation: V. Vetvicka et al., Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules, CLIN EXP IM, 115(2), 1999, pp. 229-235
Risultati:
1-7
|